Skip to main content

. 1987 Feb;80(2):119–120. doi: 10.1177/014107688708000220

Albendazole in the treatment of hydatid disease.

A Rahemtulla, A D Bryceson, D P McManus, D S Ellis

PMCID: PMC1290688 PMID: 3560142

119

Images in this article

Figure 2.
on p.119

Figure 3. A
on p.119

Figure 3. B
on p.119

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Bogan J. A., Marriner S. Analysis of benzimidazoles in body fluids by high-performance liquid chromatography. J Pharm Sci. 1980 Apr;69(4):422–423. doi: 10.1002/jps.2600690416. [DOI] [PubMed] [Google Scholar]
Bryceson A. D., Cowie A. G., Macleod C., White S., Edwards D., Smyth J. D., McManus D. P. Experience with mebendazole in the treatment of inoperable hydatid disease in England. Trans R Soc Trop Med Hyg. 1982;76(4):510–518. doi: 10.1016/0035-9203(82)90151-1. [DOI] [PubMed] [Google Scholar]
Saimot A. G., Meulemans A., Cremieux A. C., Giovanangeli M. D., Hay J. M., Delaitre B., Coulaud J. P. Albendazole as a potential treatment for human hydatidosis. Lancet. 1983 Sep 17;2(8351):652–656. doi: 10.1016/s0140-6736(83)92533-3. [DOI] [PubMed] [Google Scholar]
Smyth J. D., Barrett N. J. Procedures for testing the viability of human hydatid cysts following surgical removal, especially after chemotherapy. Trans R Soc Trop Med Hyg. 1980;74(5):649–652. doi: 10.1016/0035-9203(80)90157-1. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES